Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
General Lanthanide carriers advance next generation biomedical imaging and theranosticsBy Healthcare Propulsion StaffJuly 30, 20260 Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches that link…
